Immucell (ICCC) Total Debt (2010 - 2026)
Immucell's (ICCC) quarterly Total Debt came in at $9.1 million in Q4 2025, down 13.66% YoY from $10.5 million in Q4 2024, and down 4.12% on a QoQ basis from $9.5 million in Q3 2025.
Immucell (ICCC) Total Debt (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Total Debt data on file, last reported at $9.1 million in Q4 2025.
- Quarterly Total Debt fell 13.66% year-over-year to $9.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.1 million (down 13.66% YoY) and the FY2025 annual result came in at $9.1 million, down 13.66% from the prior year.
- Total Debt fell to $9.1 million in Q4 2025, from $9.5 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $12.3 million in Q3 2023 to a low of $9.1 million in Q4 2025.
- A 5-year average of $10.4 million and a median of $10.4 million in 2022 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2023 — Total Debt increased 17.55% — and 2025, when it dropped 13.66%.
- Tracing ICCC's Total Debt over 5 years: stood at $9.1 million in 2021, then rose by 11.94% to $10.2 million in 2022, then gained by 17.0% to $12.0 million in 2023, then retreated by 11.95% to $10.5 million in 2024, then fell by 13.66% to $9.1 million in 2025.
- The last three Total Debt figures came in at $9.1 million (Q4 2025), $9.5 million (Q3 2025), and $9.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn | 9.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.81 Mn |
| Dec 31, 2025 | 9.10 Mn |
| Sep 30, 2025 | 9.49 Mn |
| Jun 30, 2025 | 9.80 Mn |
| Mar 31, 2025 | 11.76 Mn |
| Dec 31, 2024 | 10.54 Mn |
| Sep 30, 2024 | 10.90 Mn |
| Jun 30, 2024 | 11.26 Mn |
| Mar 31, 2024 | 11.61 Mn |
| Dec 31, 2023 | 11.97 Mn |
| Sep 30, 2023 | 12.32 Mn |
| Jun 30, 2023 | 9.64 Mn |
| Mar 31, 2023 | 9.92 Mn |
| Dec 31, 2022 | 10.23 Mn |
| Sep 30, 2022 | 10.48 Mn |
| Jun 30, 2022 | 10.70 Mn |
| Mar 31, 2022 | 10.93 Mn |
| Dec 31, 2021 | 9.14 Mn |
| Sep 30, 2021 | 9.33 Mn |
| Jun 30, 2021 | 9.12 Mn |